Hirotaka Fudaba

Yufu, 8795593, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Quantitative BRAF p.V600E mutation monitoring in cerebrospinal fluid cell-free DNA reflects therapeutic response to BRAF/MEK inhibitors in papillary craniopharyngioma: a report of two cases.

Quantitative BRAF p.V600E mutation monitoring in cerebrospinal fluid cell-free DNA reflects therapeutic response to BRAF/MEK inhibitors in papillary craniopharyngioma: a report of two cases.

Journal: Acta neuropathologica communications

Published: March 04, 2026

BEND2 Immunohistochemistry as a Useful Diagnostic Marker for Astroblastomas With BEND2 Fusion.

BEND2 Immunohistochemistry as a Useful Diagnostic Marker for Astroblastomas With BEND2 Fusion.

Journal: The American journal of surgical pathology

Published: December 25, 2025

Dysfunction of inhibitory-excitatory cortical circuits induces density-dependent facilitation of motor-evoked potentials after subarachnoid hemorrhage.

Dysfunction of inhibitory-excitatory cortical circuits induces density-dependent facilitation of motor-evoked potentials after subarachnoid hemorrhage.

Journal: Frontiers in neurology

Published: August 26, 2025

Effect of Modified Encephalo-Duro-Arterial-Synangiosis on Periventricular Anastomosis in Pediatric Patients with Moyamoya Disease.

Effect of Modified Encephalo-Duro-Arterial-Synangiosis on Periventricular Anastomosis in Pediatric Patients with Moyamoya Disease.

Journal: World neurosurgery

Published: July 15, 2025

Long-term outcome of nimustine-based chemotherapy for oligodendroglioma.

Long-term outcome of nimustine-based chemotherapy for oligodendroglioma.

Journal: Neuro-oncology advances

Published: July 02, 2025

Rural medical disparities in multimodal glioblastoma treatment.

Rural medical disparities in multimodal glioblastoma treatment.

Journal: Scientific reports

Published: March 26, 2025

Chimeric oncolytic adenovirus to break away from neutralizing antibodies.

Chimeric oncolytic adenovirus to break away from neutralizing antibodies.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: March 01, 2024

Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study.

Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study.

Journal: BMJ open

Published: April 24, 2023

Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.

Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.

Journal: Journal of neuro-oncology

Published: February 27, 2023

Quantitative GABA magnetic resonance spectroscopy as a measure of motor learning function in the motor cortex after subarachnoid hemorrhage.

Quantitative GABA magnetic resonance spectroscopy as a measure of motor learning function in the motor cortex after subarachnoid hemorrhage.

Journal: Frontiers in neurology

Published: February 24, 2023

Oncolytic virus therapy for malignant gliomas: entering the new era.

Oncolytic virus therapy for malignant gliomas: entering the new era.

Journal: Expert opinion on biological therapy

Published: February 22, 2023

Monophasic-quadri-burst stimulation robustly activates bilateral swallowing motor cortices.

Monophasic-quadri-burst stimulation robustly activates bilateral swallowing motor cortices.

Journal: Frontiers in neuroscience

Published: February 11, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026